CGT
BLUE

Capital Guardian Trust’s bluebird bio BLUE Stock Holding History

Capital Guardian Trust’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$44.5M Sell
26,992
-110
-0.4% -$190K 0.6% 73
2019
Q1 		$55.2M Buy
27,102
+2,511
+10% +$4.42M 0.73% 55
2018
Q4 		$31.6M Buy
24,591
+822
+3% +$1.26M 0.5% 81
2018
Q3 		$45M Buy
23,769
+1,030
+5% +$2.13M 0.61% 72
2018
Q2 		$46.2M Buy
22,739
+159
+0.7% +$362K 0.66% 66
2018
Q1 		$49.9M Buy
+22,580
New +$57.4M 0.7% 60

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Guardian Trust's BLUE Position: Q2 2019 in Review

Capital Guardian Trust reduced its bluebird bio (BLUE) stake by 0.41% in Q2 2019, selling an estimated $190K and leaving 26,992 shares worth $44.5M. The position accounts for 0.6% of the portfolio, ranked #73.

Capital Guardian Trust first reported a position in BLUE in Q1 2018 and has held it in 6 quarters since. The position peaked at $55.2M in Q1 2019. 273 funds tracked by Wall St. Rank hold BLUE as of Q2 2019.

  • Capital Guardian Trust held 26,992 shares of bluebird bio worth $44.5M as of Q2 2019.
  • Capital Guardian Trust sold 110 bluebird bio shares in Q2 2019, an estimated $190K.
  • bluebird bio made up 0.6% of Capital Guardian Trust's portfolio in Q2 2019, its #73 holding.
  • Capital Guardian Trust first reported a position in bluebird bio in Q1 2018 and has held it in 6 quarters since.
  • Capital Guardian Trust's bluebird bio position peaked at $55.2M in Q1 2019.
  • 273 funds tracked by Wall St. Rank held bluebird bio as of Q2 2019.

Based on Capital Guardian Trust's 13F filing for Q2 2019, filed 14 Aug 2019.